Top compounds associated with response to OR2C1


Feature Type Standardized
Nominal ANOVA
mRNA FK866 GDSC1000 pan-cancer AAC -0.065 0.03
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.03
mRNA Rapamycin GDSC1000 pan-cancer AAC -0.11 0.03
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.03
mRNA Sunitinib GDSC1000 pan-cancer AAC -0.11 0.03
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.067 0.03
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.03
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.071 0.03
mRNA MS-275 CTRPv2 pan-cancer AAC -0.069 0.03
mRNA BRD-K41334119 CTRPv2 pan-cancer AAC 0.15 0.04
Download CSV